Replies to post #14904 on ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Silvr, I see that CGON stock has dropped significantly $28.50 and putting up daily 52 - week lows. Investors are now questioning their calculation of the complete response rate. Additionally, some are seeing, as you pointed out, the clarity of ANIP's stance vs the vagueness of CGON's stance on the matter.

CGON has much more to lose by their greed than ANIP in this matter. If they lose the ability to file an NDA, their stock becomes almost worthless.

Risk vs Reward make this a very big gamble by CGON for only 5% of net sales.

JMHO